IHS Chemical Week

People & Business :: People/Executives

Avantor signs development agreement with Rubicon Research for pharma excipients

11:36 AM MDT | October 16, 2012 | Lindsay Frost

Avantor Performance Materials (Center Valley, PA) has signed a collaboration agreement with Rubicon Research (Mumbai) to develop, manufacture, and market products for the functional excipient market in pharmaceuticals. The companies plan to develop a novel gastroretentive excipient that can enable molecule delivery with a window of absorption, allowing targeted delivery and a therapeutic advantage with more options for the pharmaceutical excipient segment. “The Rubicon team is excited to work with Avantor in introducing this novel polymeric material as a...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa